• Quarta-Rad posted a net loss of $104,178 for the quarter ended March 31, 2026, widening 34.58% from a year earlier.
• Revenue fell 21.38% to $25,856, while operating expenses rose 14.24% to $101,147.
• Sellavir revenue slipped 16.67% to $25,000, while its net loss widened to $69,166 from $36,169 on stock-based compensation, foreign translation loss, and the cessation of accrual of certain related party interest obligations.
• Quarta-Rad segment revenue dropped 70.35% to $856 as the company phases out its historical radiation detection product line and shifts focus to developing and commercializing CenterEye, an AI-driven call center software platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quarta-Rad Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023573), on May 15, 2026, and is solely responsible for the information contained therein.